Table 1.

DNA prevalence of HPyV6 and HPyV7 in different patient groups

Patient group (n)	HPyV6 (%)	HPyV7 (%)
SLE (5)
SLE1 (5 samples)	1 (20.0)	0 (0)
SLE2 (7 samples)	1 (14.3)	0 (0)
SLE3 (13 samples)	4 (30.8)	2 (15.4)a
SLE4 (16 samples)	4 (25.0)	3 (18.8)b
SLE5 (32 samples)	11 (34.4)	1 (3.1)c
Total samples (73)	21 (28.8)	6 (8.2)
Multiple sclerosis (30)	0 (0)	0 (0)
Psoriasis vulgaris (15)	0 (0)	0 (0)
Arthritic psoriasis (15)	0 (0)	0 (0)
HIV-positive (66)	6 (9.1)	0 (0)
Pregnant women (47)	19 (40.4)	4 (8.5)d
Blood donors (20)	0 (0)	0 (0)

^aThese samples were also HPyV6 positive

^bOne sample was also HPyV6 positive

^cThis sample was also HPyV6 positive

^dTwo samples were also positive for HPyV6